CRIS Current Research Information System

BENEVENTO, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.989
AS - Asia 1.776
EU - Europa 1.045
AF - Africa 121
SA - Sud America 79
OC - Oceania 1
Totale 5.011
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.953
VN - Vietnam 653
SG - Singapore 448
CN - Cina 342
IT - Italia 207
GB - Regno Unito 167
DE - Germania 162
SE - Svezia 122
HK - Hong Kong 119
NL - Olanda 66
IN - India 63
FR - Francia 62
BR - Brasile 51
IE - Irlanda 48
RU - Federazione Russa 48
TG - Togo 42
FI - Finlandia 40
KR - Corea 28
CI - Costa d'Avorio 27
CH - Svizzera 23
ZA - Sudafrica 22
JP - Giappone 21
CA - Canada 19
BG - Bulgaria 16
PH - Filippine 16
BD - Bangladesh 12
BE - Belgio 12
JO - Giordania 12
EE - Estonia 11
AR - Argentina 10
SC - Seychelles 10
UA - Ucraina 10
ID - Indonesia 9
PK - Pakistan 9
HR - Croazia 8
IQ - Iraq 8
NG - Nigeria 8
MX - Messico 7
TW - Taiwan 7
AT - Austria 6
MK - Macedonia 6
PL - Polonia 6
TH - Thailandia 6
CL - Cile 5
LT - Lituania 5
TR - Turchia 5
UZ - Uzbekistan 5
ES - Italia 4
VE - Venezuela 4
DZ - Algeria 3
HN - Honduras 3
KZ - Kazakistan 3
SN - Senegal 3
CO - Colombia 2
CR - Costa Rica 2
EC - Ecuador 2
GR - Grecia 2
HU - Ungheria 2
LV - Lettonia 2
PE - Perù 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
MD - Moldavia 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.011
Salva come PNG Salva come JPEG
Città #
Singapore 313
Ashburn 284
Fairfield 173
Chandler 168
Ho Chi Minh City 152
Southend 142
Hanoi 135
San Jose 102
Dong Ket 100
Hong Kong 98
Woodbridge 88
Santa Clara 76
Seattle 76
Bologna 68
Boardman 63
Houston 63
Wilmington 57
Beijing 51
Dublin 48
Hefei 43
Princeton 43
Lomé 42
Cambridge 41
Dallas 41
Ann Arbor 39
New York 36
Da Nang 31
Los Angeles 31
Abidjan 27
Munich 25
Helsinki 24
Lauterbourg 23
Seoul 23
Bern 21
Council Bluffs 21
Haiphong 21
Sofia 16
Tokyo 16
Buffalo 14
Frankfurt am Main 14
Redmond 14
Westminster 14
Milan 13
Turin 13
Amman 12
Falkenstein 12
Nanjing 12
Washington 12
Brussels 11
Shanghai 11
Shenyang 11
Berlin 10
Orem 10
Redondo Beach 10
Amsterdam 9
Nuremberg 9
Turku 9
Abeokuta 8
Bremen 8
Florence 8
Guangzhou 8
London 8
São Paulo 8
Hải Dương 7
Johannesburg 7
Lappeenranta 7
Padova 7
Quận Ba 7
Saint Petersburg 7
The Dalles 7
Can Tho 6
Cedar Rapids 6
Chicago 6
Des Moines 6
Fort Worth 6
Jakarta 6
Jinan 6
Montreal 6
Nha Trang 6
Rome 6
Skopje 6
Vũng Tàu 6
Zhengzhou 6
Brooklyn 5
Bắc Ninh 5
Hangzhou 5
Ninh Bình 5
San Diego 5
Warsaw 5
Bengaluru 4
Biên Hòa 4
Chennai 4
Chongqing 4
Huế 4
Mexico City 4
Mountain View 4
Paris 4
Redwood City 4
Taiyuan 4
Thái Bình 4
Totale 3.290
Salva come PNG Salva come JPEG
Nome #
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 244
Pattern of macrovascular invasion in hepatocellular carcinoma 242
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 240
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 237
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 234
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 226
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 219
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 213
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 206
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 196
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib 195
Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear 176
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives 158
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: Correlation with MGMT promoter methylation status 157
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 156
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 156
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 152
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) 151
Experience with regorafenib in the treatment of hepatocellular carcinoma 149
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 140
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure 136
Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019 133
SAT-453-Effects of sorafenib on pancreatic volume and their clinical implications in patients with hepatocellular carcinoma 128
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery 124
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 124
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 119
null 117
An update on atezolizumab for hepatocellular carcinoma 95
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC 83
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma 82
null 77
null 56
Totale 5.121
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.369
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021103 0 0 0 0 0 0 0 0 0 0 0 103
2021/2022507 52 7 15 21 46 32 9 33 19 31 178 64
2022/2023625 46 90 30 82 47 49 36 36 117 14 35 43
2023/2024291 16 50 29 18 41 64 10 19 21 11 5 7
2024/2025765 41 76 71 63 91 35 75 30 12 86 62 123
2025/20262.026 182 151 155 118 189 87 385 53 442 126 70 68
Totale 5.121